Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:3.2.1.20 (alpha-glucosidase)
 4,237 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Jejunal sucrase is known to display glucocorticoid responsiveness from birth through day 17 but not beyond that age. The aim of the current study was to determine whether this abrupt loss of responsiveness was shared by maltase, lactase, and acid beta-galactosidase. Glucocorticoid concentrations were manipulated by both adrenalectomy (ADX) and by administration of cortisone acetate (CA). Surgery or treatment was performed on each day from 16--22 days of age. Maltase activity was reduced by ADX at day 18 and earlier and was increased by CA at days 16 and 17. There were no effects at later ages. Acid beta-galactosidase was increased by ADX only at day 18 and earlier and was decreased by CA only at day 16. Lactase activity was increased by ADX at all ages up to and including day 20 but was reduced by CA only at days 16 and 17. Thus, we conclude that loss of glucocorticoid responsiveness at a relatively early stage of development is a common feature of both brush-border and lysosomal enzymes of the small intestine.
 ...
PMID:Coordinate loss of glucocorticoid responsiveness by intestinal enzymes during postnatal development. 680 95

Both corticosterone and T4 have been previously implicated as causal factors in the ontogenic increases in jejunal sucrase and maltase activities during the third week of life in the rat. Furthermore, it is known that the administration of exogenous T4 during the developmental period causes significant increases in serum corticosterone concentrations. To determine whether the effects of T4 on sucrase and maltase are secondary to the corticosterone rise, we examined the effect of T4 administration in adrenalectomized (adX) pups. Serum corticosterone was measured in all operated animals. Some of the adX pups had substantial concentrations of circulating corticosterone. In adX pups with serum corticosterone levels below 0.1 microgram/dl, there was no effect of T4 on either maltase or sucrase activity. We also studied the effect of propylthiouracil-induced hypothyroidism on sucrase and maltase. At 21 days of age, both enzyme activities were significantly reduced in hypothyroid pups. Injections of either T4 or cortisone acetate were equally effective in restoring activities to normal. For sucrase, there was no further increase in activity when both hormones were administered. For maltase, the combined treatment gave activities that were significantly higher than those with either hormone alone. We conclude that for both sucrase and maltase, the effects of changes in thyroid status are primarily due to the accompanying changes in serum corticosterone. The normal rate of development of both enzymes appears to be principally under glucocorticoid control, although for maltase, T4 may have a facilitory action.
 ...
PMID:Relative importance of corticosterone and thyroxine in the postnatal development of sucrase and maltase in rat small intestine. 704 75

The differential effects of phagocytic and chemical stimuli on neutrophil enzyme and specific protein release were compared. Phorbol myristate acetate (PMA) stimulated release of the specific granule matrix marker, vitamin B-12-binding protein in a dose-dependent manner. Subcellular fractionation by sucrose density gradient centrifugation indicated that the residual vitamin B-12-binding protein is associated with the specific granule fraction. In contrast, neutral alpha-glucosidase and adenosine diphosphatase, associated with specific granule membranes, were not released by PMA. Subcellular fractionation studies suggest that fusion of the specific granule membrane and plasma membrane occurs, thus translocating the adenosine diphosphatase to the cell surface. The relevance of this finding to the possible role of nucleoside phosphatases in limiting platelet aggregation is discussed. Serum-treated zymosan particles also caused a selective release of vitamin B-12-binding protein from the specific granule without release of alpha-glucosidase and adenosine diphosphatase. Neither PMA nor opsonized zymosan caused significant release of azurophil, tertiary granule or cytosol marker enzymes.
 ...
PMID:The release of granule components from human polymorphonuclear leukocytes in response to both phagocytic and chemical stimuli. 715 Jun 43

We investigated the ability of Bacteroides thetaiotaomicron, an obligate anaerobe from human colonic microflora, to grow in a carbohydrate-limited continuous culture at generation times ranging from 3.5 to 28 h per division. Four carbohydrates were tested: glucose, N-acetylglucosamine, glucuronic acid, and glucosamine. At a generation time of 3.5 h per division, the growth yields for bacteria growing on glucose, N-acetylglucosamine, and glucuronic acid were 76, 68, and 50 g of cells (dry weight) per mol of substrate, respectively. Growth yields at 28 h per division were 61, 52, and 37 g/mol of substrate, respectively. When glucosamine was the carbohydrate source, a stable population of bacteria was attainable only at generation times longer than 12 h per division. Growth yields at 15 and 32 h per division were 11 and 33 g/mol of substrate, respectively. There was no significant variation with increasing generation times in the specific activities of selected glycolytic enzymes, of disaccharidases such as alpha- and beta-glucosidases and alpha- and beta-galactosidases, or of the polysaccharidase chondroitin sulfate lyase. By contrast, the pattern of fermentation products varied with both the generation time and the carbon source. At a generation time of 3.5 h per division, the main products from the fermentation of glucose were acetate and succinate, with a trace of propionate. At 28 h per division, propionate concentrations were higher and succinate concentrations were lower than at 3.5 h per division. The products from the fermentation of glucosamine were the same as those from glucose fermentation. However, when N-acetylglucosamine was fermented, the concentration of acetate was much higher at all generation times than when glucose was the carbon source. When glucuronic acid was the carbon source, acetate was the main fermentation product, and only traces of propionate and succinate were detected. Another characteristic that varied with the growth rate was the ability of B. thetaiotaomicron to produce the inducible enzyme alpha-glucosidase when exposed to maltose. The ability of the organism to produce this enzyme declined with increasing generation times.
 ...
PMID:Effect of long generation times on growth of Bacteroides thetaiotaomicron in carbohydrate-induced continuous culture. 724 86

Dogs are particularly susceptible to development of glucocorticoid-induced hepatopathy, but the mechanisms are not well understood. We investigated the pathogenesis of glucocorticoid hepatopathy by examining sequential morphologic and biochemical changes in the liver of dogs during steroid administration. Six adult Beagles were given prednisolone acetate (4mg/kg of body weight, once daily for 24 days IM). Serum samples and percutaneous liver biopsy specimens were obtained before the start of the study (treatment day [TD] 0) and at TD 5, 10, 15, and 25. There were significant (P < 0.05) and progressive increases in serum activities of alkaline phosphatase, gamma-glutamyltransferase, and alanine transaminase. Light microscopic changes in liver biopsy specimens included progressive hepatocellular swelling and vacuolation. Electron microscopy revealed glycogen accumulation, peripheral displacement of organelles, and prominent dilatation of bile canaliculi, compared with findings at TD 0. Liver biopsy specimens taken at TD 25 had significantly (P < 0.05) increased activities of the plasma membrane enzymes, alkaline phosphatase and gamma-glutamyltransferase, and 5'-nucleotidase was significantly (P < 0.001) decreased. Subcellular fractionation on reorientating sucrose density gradients revealed high-density peaks of alkaline phosphatase and gamma-glutamyltransferase, compatible with a specific increase in the biliary canalicular component of the enzyme activities. Neutral alpha-glucosidase activity was shifted to the denser fractions, indicative of an increase in the proportion of rough to smooth endoplasmic reticulum and consistent with enhanced synthesis of plasma membrane proteins. There also was evidence for progressive increase in fragility of intracellular organelles, particularly lysosomes. These findings indicate that glucocorticoid hepatopathy in dogs is associated with progressive alterations not only to the plasma membrane, but also to other subcellular organelles.
 ...
PMID:Subcellular pathologic features of glucocorticoid-induced hepatopathy in dogs. 757 58

Ammonia is a natural lysosomotropic compound. Concentrations of ammonium acetate > 2 mM impaired the phagocytic activity of BV-2 cells, an immortalized microglial cell line, as was determined by the uptake of fluorescent latex microspheres of different sizes. In contrast, an increase in the uptake of fluorescent dextran was observed with the elevation in ammonium acetate concentrations. This indicates that ammonia affects phagocytotic and pinocytotic activities of BV-2 cells differently. Interferon-gamma- and polyinosinic-polycytidylic acid-stimulated secretion of IL1 alpha as well as LPS-stimulated secretion of IL6 decreased with an elevation in ammonium acetate concentrations. The constitutive secretion of IL1 alpha was not significantly affected by ammonium acetate. However, an increase in LPS-stimulated IL1 alpha secretion was observed at 10 mM and 20 mM ammonium acetate. High concentrations of ammonia affected the activity of lysosomal enzymes of the BV-2 cells. Acid phosphatase and alpha-glucosidase activities increased with the increase in ammonium acetate up to 20 mM. The activity of cathepsin D was increased at 5 mM, but decreased at higher ammonia concentrations. The effects of ammonia on microglial functions are discussed with respect to pathogenetic mechanisms of dementia of the Alzheimer type.
 ...
PMID:Effect of ammonia on endocytosis, cytokine production and lysosomal enzyme activity of a microglial cell line. 782 5

We have previously presented indirect in vivo evidence for the involvement of islet acid glucan-1,4-alpha-glucosidase (acid amyloglucosidase), a lysosomal glucose-producing enzyme, in certain insulin secretory processes. In the present in vitro and in vivo investigation, we studied whether differential changes in islet acid amyloglucosidase activity would be related to the insulin secretory response induced by two mechanistically different secretagogues, the sulphonylurea derivative, glibenclamide and the acetylcholine receptor agonist, carbachol. It was observed that the selective alpha-glucosidehydrolase inhibitors emiglitate and acarbose markedly reduced glibenclamide-induced insulin release from isolated islets. Insulin release stimulated by carbachol or the protein kinase C activator TPA (12-O-tetradecanoylphorbol 13-acetate), was not inhibited. Basal insulin secretion was unaffected by emiglitate and acarbose. Further, pretreatment of mice with emiglitate resulted in a marked reduction of the in vivo insulin response to glibenclamide. Moreover, in vivo pretreatment with purified fungal amyloglucosidase ('enzyme replacement'), a procedure known to increase islet amyloglucosidase activity, greatly enhanced the insulin response to i.v. glibenclamide. This insulin release was accompanied by a marked depression of the blood glucose levels. In contrast, enzyme pretreatment did not influence the insulin response or the blood glucose levels after carbachol. The data strongly suggest that islet acid amyloglucosidase is involved in the insulin secretory processes induced by glibenclamide but not in those involving stimulation of muscarinic receptors or direct activation of protein kinase C. The results also indicate separate or at least partially separate pathways for insulin release induced by glibenclamide and cholinergic stimulation.
 ...
PMID:Changes in islet glucan-1,4-alpha-glucosidase activity modulate sulphonylurea-induced but not cholinergic insulin secretion. 827 68

The bioenergetic role of the reduction of elemental sulfur (S0) in the hyperthermophilic archaeon (formerly archaebacterium) Pyrococcus furiosus was investigated with chemostat cultures with maltose as the limiting carbon source. The maximal yield coefficient was 99.8 g (dry weight) of cells (cdw) per mol of maltose in the presence of S0 but only 51.3 g (cdw) per mol of maltose if S0 was omitted. However, the corresponding maintenance coefficients were not found to be significantly different. The primary fermentation products detected were H2, CO2, and acetate, together with H2S, when S0 was also added to the growth medium. If H2S was summed with H2 to represent total reducing equivalents released during fermentation, the presence of S0 had no significant effect on the pattern of fermentation products. In addition, the presence of S0 did not significantly affect the specific activities in cell extracts of hydrogenase, sulfur reductase, alpha-glucosidase, or protease. These results suggest either that S0 reduction is an energy-conserving reaction, i.e., S0 respiration, or that S0 has a stimulatory effect on or helps overcome a process that is yield limiting. A modification of the Entner-Doudoroff glycolytic pathway has been proposed as the primary route of glucose catabolism in P. furiosus (S. Mukund and M. W. W. Adams, J. Biol. Chem. 266:14208-14216, 1991). Operation of this pathway should yield 4 mol of ATP per mol of maltose oxidized, from which one can calculate a value of 12.9 g (cdw) per mol of ATP for non-S0 growth. Comparison of this value to the yield data for growth in the presence of S0 reduction is equivalent to an ATP yield of 0.5 mol of ATP per mol of S0 reduced. Possible mechanism to account for this apparent energy conservation are discussed.
 ...
PMID:Bioenergetics of sulfur reduction in the hyperthermophilic archaeon Pyrococcus furiosus. 844 88

The development of hydrolase activity in the intestinal brush border membrane is important for the maturation of digestive function in early life. The development and glucocorticoid control of intestinal enzymes were investigated in the mink (Mustela vison), a carnivorous species, in which the intestine matures relatively late in postnatal life. Mink kits (n = 110 from 20 litters) were either not treated or injected intramuscularly for 7 d with saline, adrenocorticotropic hormone [ACTH, 50 micrograms/(kg.d)] or cortisol 21-acetate [synthetic glucocorticoid, 50 mg/(kg.d)]. The kits were killed at 2, 4, 6, 8 or 10 wk of age and the proximal, middle and distal intestine removed for analyses. Lactase activity was maximal at 4 wk and decreased to about 5% of this level during the following 2 wk. Cortisol treatment stimulated total lactase activity at 2 wk (170% that of controls, P < 0.05) and reduced this activity at 4 wk (20% that of controls, P < 0.001). Aminopeptidases N and A underwent their major developmental increases in activity at 4-6 wk and again, enzyme development was stimulated by cortisol. Other enzymes showed either a gradual increase (maltase), a slight decrease (dipeptidylpeptidase IV) or no consistent change (sucrase) in activity with advancing age from 2 to 10 wk, but the activities remained highest in cortisol-treated kits. Treatment with ACTH enhanced the activity of all enzymes at 2 wk but had little effect thereafter. Intestinal hydrolases develop later in the mink and are sensitive to glucocorticoid induction for a longer period in postnatal life than in species such as rats, pigs or humans. The mink is a useful model in studies of the regulatory mechanisms which influence the development of intestinal brush border hydrolases.
 ...
PMID:Intestinal hydrolytic activity in young mink (Mustela vison) develops slowly postnatally and exhibits late sensitivity to glucocorticoids. 881 92

Glucose homeostasis is maintained by a balance between the release and action of insulin, and the counterregulatory responses mediated principally by glucagon, catecholamines, growth hormone and cortisol. Hence, the effects of a drug on glucose metabolism may be mediated by any of these agents singly or in combination. Host factors, such as inherent glucoregulatory mechanisms, concurrent diseases, organ function and concomitant medications also increase the risk of drug-induced disturbances of glucose homeostasis in susceptible individuals. By far the most important agents causing hypoglycaemia are insulin and the sulphonylureas. Alcohol (ethanol), over-zealous glycaemic control, hypoglycaemic unawareness, detective counterregulation especially in insulin-dependent diabetes mellitus (IDDM), and renal and liver impairment are all important predisposing factors. Although antihyperglycaemic agents such as metformin and alpha-glucosidase inhibitors do not cause hypoglycaemia alone, they may enhance the hypoglycaemic effects of potent hypoglycaemic agents such as insulin and sulphonylureas. On the other hand, the potential hypoglycaemic effects of ACE inhibitors, alpha-blockers, lipid-lowering agents and recombinant human insulin-like growth factor demonstrated in experimental settings, are of potential therapeutic interest. Iatrogenic hypoglycaemia and intensive insulin treatment are associated with hypoglycaemic unawareness which may be obviated by meticulous avoidance of hypoglycaemia. Effective patient education remains an important preventive measure. Oral glucose is used to treat mild hypoglycaemic episodes while more severe episodes are treated by intravenous glucose or glucagon. Nasal glucagon and theophylline are other experimental measures to improve recovery from hypoglycaemia. In refractory hypoglycaemia due to hyperinsulinaemia such as during sulphonylurea overdosage or quinine treatment, the long-acting somatostatin, octreotide, may suppress insulin release and restore euglycaemia. Diuretics, beta-blockers, sympathomimetics, corticosteroids and sex hormones are commonly prescribed drugs which may have adverse effects on carbohydrate metabolism especially in patients with diabetes mellitus or those who are at risk of developing glucose intolerance. Pentamidine was frequently associated with dysglycaemia due to its pancreatic beta-cell cytotoxic effects but is now used less often to treat Pneumocystis carinii pneumonia in immunosuppressed patients. Despite the large number of anecdotal reports of drug-induced disturbances of glucose metabolism, many of the so-called adverse drug reactions were either idiosyncratic or coincidental. Nevertheless, they emphasise the complex nature of glucose homeostasis and its potential interactions with drugs, host factors and disease states. An understanding of these relationships may allow more critical interpretation of these clinical observations, better prediction of drug induced adverse effects on carbohydrate metabolism and the implementation of more rational therapy. Hence, the hypoglycaemic effects of a drug may be turned to a therapeutic advantage in patients with glucose intolerance. Similarly, the hyperglycaemic effect of a drug may help to treat refractory hypoglycaemia.
 ...
PMID:Drug-induced disorders of glucose metabolism. Mechanisms and management. 888 64


<< Previous 1 2 3 4 5 6 7 Next >>